Immunoprecipitation Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast 2024-2028

Published: Mar 2024 Pages: 161 SKU: IRTNTR77701

Immunoprecipitation Market Forecast 2024-2028

The global immunoprecipitation market size is estimated to grow by USD 270.1 million, at a CAGR of 6.01% between 2023 and 2028. 

Immunoprecipitation plays a pivotal role in antigen purification and downstream processing, impacting both time and cost. Market trends show continuous efforts to enhance productivity and efficiency. Developments in large-scale chromatography processes include novel resin properties, improved protein resin for mAb capture, single-use technologies, exploring commercial-scale continuous chromatography, and automation. The shift to modern immunoprecipitation-based production processes emphasizes large-scale capabilities, targeting challenges in purifying mAbs, blood factors, antibody fragments, gene therapy vectors, and viral vaccines. Mass chromatography, binding with immunoglobulin G segments, enhances immunoprecipitation efficacy in purifying standard mAbs. Growing research and development in biopharmaceuticals indicate increased immunoprecipitation adoption, driving the market's growth during the forecast period.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by End-user, Type and Geography Analysis

The market encompasses a wide array of products and services catering to researchers and pharmaceutical & biotechnology companies engaged in drug development, disease study, and immunotherapy. Key components include kits, IP assays, antigens, proteins, and antibodies facilitating the study of protein-protein interactions and disease mechanisms related to autoimmune diseases and oncology. Advanced techniques like Chromatin Immunoprecipitation (ChIP) technology, ChIP-seq, and RNA immunoprecipitation offer insights into genomics, epigenetics, and individual immunoprecipitation. The market also sees applications in cellular and genetic therapies, with technological advancements driving innovation in immunology and immuno-oncology. Pharmaceutical & biotechnology companies are major players in this market, leveraging Chromatrap Immunoprecipitation and co-immunoprecipitation techniques for drug discovery. Collaboration with federal bodies and integration into the healthcare sector further bolsters market growth, fostering a dynamic landscape for immunoprecipitation products and services.

End-user Analysis

The market share growth by the academic and research institutes segment will be significant during the forecast period. Academic and research institutes segment include the use of fluidic technology for research purposes, such as microfluidics research, neuroscience research, cellular research, and other life science experiments involving chromatography and mass spectrometry. 

Get a glance at the market contribution of various segments Download PDF Sample

The academic and research institutes segment was the largest and was valued at USD 293.62 million in 2018. Research institutes are the centers where tests are performed on clinical specimens for monitoring patients' health related to the diagnosis, treatment, and prevention of various neurological disorders. Moreover, laboratories get references to conduct tests and clinical trials from pharmaceutical and biotechnology companies, corporate offices, and insurance companies. Hospitals, companies, and clinics refer the tests to reference research institutes to reduce the data management cost. Research centers are linked to national and international universities and medical centers to conduct clinical research. Therefore, increasing R&D on neuroscience antibodies is expected to drive the growth of the academic and research institutes segment and boost the growth of the market during the forecast period.

Type Analysis 

Chromatin immunoprecipitation (ChIP) is a pivotal technique within the global immunoprecipitation market, used to understand and analyze the complex interactions between proteins and deoxyribonucleic acid (DNA). This method enables researchers to investigate the binding patterns of proteins, such as transcription factors and histones, to specific DNA sequences, along with the entire genome, thus helping in providing a better understanding of their regulatory functions and mechanisms.  As the demand for precision medicine grows, the ChIP technique becomes integral in exploring epigenetic contributions to diseases, opening avenues for developing targeted therapies. Such factors are expected to fuel the growth of the chromatin immunoprecipitation segment, which will thereby drive the growth of the global immunoprecipitation market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America, particularly the US and Canada, boasts world-class research institutions, universities, and medical centres. Globally, North America is the largest market for immunoprecipitation and is estimated to show significant growth. This is attributed to the ever-increasing demand for pharmaceutical drugs and products. There is also an increasing demand for immunoprecipitation from biotechnological firms, academic institutes, and research institutes. The strong distribution networks in countries such as the US and Canada and the increasing focus of pharmaceutical companies on drug discovery and development are driving the growth of the regional market. 

In addition, organizations such as the National Institutes of Health and the Biomedical Advanced Research and Development Authority have also increased their funding for such research. These organizations provide funding to progress clinical trials and develop new medicines for various diseases, which increase the demand in the region. The growth of monoclonal antibody therapeutics usage in the region is strong and is likely to increase the demand for immunoprecipitation during the forecast period. The increased use of modern chromatography techniques for food analysis and diagnostic purposes is also anticipated to drive regional market growth during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Active Motif Inc - The company offers immunoprecipitation products such as ChIP-IT Express Chromatin Immunoprecipitation Kits which provides a streamlined protocol using protein G-coated magnetic beads, making it possible to perform ChIP in just 1 day.

Active Motif Inc., Agilent Technologies Inc., Becton Dickinson and Company, Bio Rad Laboratories Inc., Cell Signaling Technology Inc., Chargen Life Sciences LLP, CLOUD CLONE CORP., Creative Biolabs, Danaher Corp., GenScript Biotech Corp., JSR Micro Inc., Merck KGaA, OriGene Technologies Inc., PerkinElmer Inc, Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The market thrives on a surge in research involving Kits, IP assays, and Antigens. Protein-protein interactions are crucial in unveiling disease mechanisms and aiding drug development. Researchers leverage cutting-edge techniques in Immunotherapy, Genomics, and Microbiome studies, advancing the understanding of various diseases. Federal bodies' support fuels healthcare sectors, especially in Oncology and Immunology, while immuno-oncology gains prominence. Technological strides, such as Chromatin Immunoprecipitation techniques and innovative tools like Chromatrap Immunoprecipitation (ChIP) technology, enhance epigenetic studies. Challenges include optimizing ChIP-seq, individual immunoprecipitation, and co-immunoprecipitation methods, ensuring the efficacy of RNA immunoprecipitation amid diverse applications. Antibodies and beads play pivotal roles, with pharmaceutical and biotechnology companies driving innovation. Our researchers analyzed the market research and growth data with 2023  as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of trends and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Significant  Trends

The rising number of genome projects is an emerging trend shaping market growth. In recent years, a surge in genome projects, exemplified by the 2020 initiation of the Human Genome Project (HGP) in India, underscores the global effort to comprehend the human genome. These projects, illuminating genetic variations and disease-causing mutations specific to populations, contribute to creating genetic maps. Researchers leverage genome projects to unravel gene and protein functions, particularly vital in medicine, biotechnology, and life sciences.

Moreover, the expanding significance of genome projects propels researchers into genomics, where epigenetics solutions uncover the intricate role of DNA and genes in human ailments. Pharmacogenomics, an advancing field designing personalized medicine based on genetic makeup, promises substantial growth. The intensifying focus on genome projects is steering the widespread adoption of immunoprecipitation techniques, particularly for applications like DNA sequencing, fostering the market during the forecast period. 

Major  Challenges

The lack of skilled professionals is a significant challenge hindering market growth. The selection of an immunoprecipitation technique for complex mixture analysis necessitates careful consideration of factors such as chemical composition, nature, and physical properties of the target substance. The appropriate technique choice significantly influences the purification process's efficacy, impacting direct and indirect expenses and time to market. Despite the advent of advanced technologies, a shortage of skilled professionals proficient in chromatography equipment and operations poses a challenge.

Additionally, optimal equipment utilization is critical, and inconsistencies, like column packing issues, can compromise product yield and purity. Training programs become essential, yet recruiting experienced personnel remains challenging, limiting immunoprecipitation adoption. The scarcity of skilled professionals is anticipated to impede the market's growth during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • End-user Outlook
    • Academic and research institutes
    • Contract research organizations
    • Pharmaceutical and biotechnology companies
  • Type Outlook
    • Chromatin immunoprecipitation
    • Individual protein immunoprecipitation
    • Co-immunoprecipitation
    • RNA immunoprecipitation
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

Market Analyst Overview 

The market exhibits a robust outlook driven by an extensive array of applications across the life sciences industry. Fueled by advancements in modern genetic techniques and research activities, individual immunoprecipitation plays a pivotal role in studying autoimmune diseases, antigen-antibody interactions, and genomics research. Pharmaceutical and biotechnology companies, along with academic and research institutes, are key end-users, leveraging primary antibodies, secondary antibodies, agarose beads, and buffers for varied applications. The market's growth is further accelerated by R&D activities addressing diseases like central nervous disorders, cancers, and cardiovascular diseases.

Moreover, the notable contributors include the National Institute of Allergy and Infectious Diseases (NIAID) and the International Agency for Research on Cancer (IARC), emphasizing the market's significance in cutting-edge research initiatives. The advent of innovative technologies like Chromatrap and applications in SARS-CoV2 infection underscores immunoprecipitation's pivotal role in addressing contemporary healthcare challenges. The market's trajectory aligns with ongoing advancements and research pursuits across diverse scientific domains.

Market Scope

Report Coverage

Details

Page number

161

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.01%

Market Growth 2024-2028

USD 270.1 million

Market structure

Fragmented

YoY growth 2023-2024(%)

5.39

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Active Motif Inc., Agilent Technologies Inc., Becton Dickinson and Company, Bio Rad Laboratories Inc., Cell Signaling Technology Inc., Chargen Life Sciences LLP, CLOUD CLONE CORP., Creative Biolabs, Danaher Corp., GenScript Biotech Corp., JSR Micro Inc., Merck KGaA, OriGene Technologies Inc., PerkinElmer Inc, Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the between 2024 and 2028
  • Precise estimation of the size of the size and its contribution n of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global immunoprecipitation market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global immunoprecipitation market 2018 - 2022 ($ million)
    • 4.2 End-User Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-User Segment 2018 - 2022 ($ million)
    • 4.3 Type Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Academic and research institutes - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
    • 6.4 Contract research organizations - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
    • 6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
      • Exhibit 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
      • Exhibit 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ million)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 48: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Exhibit 50: Chart on Comparison by Type
      • Exhibit 51: Data Table on Comparison by Type
    • 7.3 Chromatin immunoprecipitation - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
    • 7.4 Individual protein immunoprecipitation - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
    • 7.5 Co-immunoprecipitation - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
      • Exhibit 61: Data Table on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
      • Exhibit 62: Chart on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
    • 7.6 RNA immunoprecipitation - Market size and forecast 2023-2028
      • Exhibit 64: Chart on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
      • Exhibit 65: Data Table on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
      • Exhibit 66: Chart on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
      • Exhibit 67: Data Table on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
    • 7.7 Market opportunity by Type
      • Exhibit 68: Market opportunity by Type ($ million)
      • Exhibit 69: Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 UK - Market size and forecast 2023-2028
      • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.9 China - Market size and forecast 2023-2028
      • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.10 Germany - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ million)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 Active Motif Inc.
              • Exhibit 119: Active Motif Inc. - Overview
              • Exhibit 120: Active Motif Inc. - Product / Service
              • Exhibit 121: Active Motif Inc. - Key offerings
            • 12.4 Agilent Technologies Inc.
              • Exhibit 122: Agilent Technologies Inc. - Overview
              • Exhibit 123: Agilent Technologies Inc. - Business segments
              • Exhibit 124: Agilent Technologies Inc. - Key news
              • Exhibit 125: Agilent Technologies Inc. - Key offerings
              • Exhibit 126: Agilent Technologies Inc. - Segment focus
            • 12.5 Becton Dickinson and Company
              • Exhibit 127: Becton Dickinson and Company - Overview
              • Exhibit 128: Becton Dickinson and Company - Business segments
              • Exhibit 129: Becton Dickinson and Company - Key news
              • Exhibit 130: Becton Dickinson and Company - Key offerings
              • Exhibit 131: Becton Dickinson and Company - Segment focus
            • 12.6 Bio Rad Laboratories Inc.
              • Exhibit 132: Bio Rad Laboratories Inc. - Overview
              • Exhibit 133: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 134: Bio Rad Laboratories Inc. - Key news
              • Exhibit 135: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 136: Bio Rad Laboratories Inc. - Segment focus
            • 12.7 Cell Signaling Technology Inc.
              • Exhibit 137: Cell Signaling Technology Inc. - Overview
              • Exhibit 138: Cell Signaling Technology Inc. - Product / Service
              • Exhibit 139: Cell Signaling Technology Inc. - Key offerings
            • 12.8 Danaher Corp.
              • Exhibit 140: Danaher Corp. - Overview
              • Exhibit 141: Danaher Corp. - Business segments
              • Exhibit 142: Danaher Corp. - Key news
              • Exhibit 143: Danaher Corp. - Key offerings
              • Exhibit 144: Danaher Corp. - Segment focus
            • 12.9 GenScript Biotech Corp.
              • Exhibit 145: GenScript Biotech Corp. - Overview
              • Exhibit 146: GenScript Biotech Corp. - Business segments
              • Exhibit 147: GenScript Biotech Corp. - Key news
              • Exhibit 148: GenScript Biotech Corp. - Key offerings
              • Exhibit 149: GenScript Biotech Corp. - Segment focus
            • 12.10 JSR Micro Inc.
              • Exhibit 150: JSR Micro Inc. - Overview
              • Exhibit 151: JSR Micro Inc. - Product / Service
              • Exhibit 152: JSR Micro Inc. - Key offerings
            • 12.11 Merck KGaA
              • Exhibit 153: Merck KGaA - Overview
              • Exhibit 154: Merck KGaA - Business segments
              • Exhibit 155: Merck KGaA - Key news
              • Exhibit 156: Merck KGaA - Key offerings
              • Exhibit 157: Merck KGaA - Segment focus
            • 12.12 OriGene Technologies Inc.
              • Exhibit 158: OriGene Technologies Inc. - Overview
              • Exhibit 159: OriGene Technologies Inc. - Product / Service
              • Exhibit 160: OriGene Technologies Inc. - Key offerings
            • 12.13 PerkinElmer Inc
              • Exhibit 161: PerkinElmer Inc - Overview
              • Exhibit 162: PerkinElmer Inc - Business segments
              • Exhibit 163: PerkinElmer Inc - Key news
              • Exhibit 164: PerkinElmer Inc - Key offerings
              • Exhibit 165: PerkinElmer Inc - Segment focus
            • 12.14 Proteintech Group Inc.
              • Exhibit 166: Proteintech Group Inc. - Overview
              • Exhibit 167: Proteintech Group Inc. - Product / Service
              • Exhibit 168: Proteintech Group Inc. - Key offerings
            • 12.15 Rockland Immunochemicals Inc.
              • Exhibit 169: Rockland Immunochemicals Inc. - Overview
              • Exhibit 170: Rockland Immunochemicals Inc. - Product / Service
              • Exhibit 171: Rockland Immunochemicals Inc. - Key offerings
            • 12.16 Santa Cruz Biotechnology Inc.
              • Exhibit 172: Santa Cruz Biotechnology Inc. - Overview
              • Exhibit 173: Santa Cruz Biotechnology Inc. - Product / Service
              • Exhibit 174: Santa Cruz Biotechnology Inc. - Key offerings
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 175: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 176: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 177: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 178: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 179: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 180: Inclusions checklist
                • Exhibit 181: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 182: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 183: Research methodology
                • Exhibit 184: Validation techniques employed for market sizing
                • Exhibit 185: Information sources
              • 13.5 List of abbreviations
                • Exhibit 186: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              immunoprecipitation market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis